In Memorium—Martin M. Katz, PhD (1927–2017)

    loading  Checking for direct PDF access through Ovid

Excerpt

The field of clinical psychopharmacology has lost another of its pioneers. On January 12, 2017, Martin M. Katz, PhD, succumbed to a failing heart. I first met Marty, as he told many to call him, in the early 1960s. He was part of a terrific group in the extramural program of the National Institute of Mental Health, which included four other pioneers who have also passed away, Mitchell (Mitch) Balter, Seymour (Sy) Fisher, Jonathan Cole, and Eberhard (Uhli) Uhlenhuth (who died in 2016). We were all friends and shared a desire to connect the clinical and basic science aspects of psychopharmacology. Mitch and Jonathan were members of the editorial board of the Journal of Clinical Psychopharmacology; Marty was a strong supporter who regularly gave us advice and helped immeasurably by reviewing papers that focused on depression and its treatment.
Marty was a prodigious and hardworking contributor to psychopharmacology. We last connected over the telephone in October 2016 when we discussed his recently written book, Clinical Trials of Antidepressants: How Changing the Model Can Uncover New, More Effective Molecules, published by Springer in February 2016. In a brief guide of 66 pages in length, Marty discusses the limitations of existing approaches to developing therapies and studying mood disorders and depression in particular. He proposes improvements in assessment tools and clinical trial protocols and argues for a better framework of understanding of depression based on current thinking about the basic biology of mood and its regulation and on what we know and do not know about the mechanisms of action of available treatments.
I never knew Marty's family, except by name: Barbara, his wife for 69 years, his daughter Nancie, and his son Pete. I am told he also had 2 granddaughters. We at the Journal of Clinical Psychopharmacology extend our deepest sympathies to the Katz family. May you always remember the love you shared and the positive times you spent together. I am certain that all of his colleagues will remember him fondly and always value his scholarship and other contributions.
Richard I.
    loading  Loading Related Articles